SCHEMBL13870939

SCHEMBL13870939

COc1cc2ccc(-c3ccc(C)c(C)c3)nc2cc1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.55
NPC1 O15118 3/20 0.55
ALDH1A1 P00352 3/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
RAB9A P51151 2/20 0.55
PDGFRB P09619 6/20 0.49
PDGFRA P16234 6/20 0.49
MAPT P10636 2/20 0.49
RAC1 P63000 2/20 0.43
GLA P06280 1/20 0.42
GAA P10253 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
TP53 P04637 1/20 0.42
KMO O15229 1/20 0.42
ACACA Q13085 1/20 0.41
NQO2 P16083 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
SLC2A1 P11166 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16487823 0.86 KDM4E (0.45) KDM4ENPC1ALDH1A1SMN1; SMN2RAB9A
SCHEMBL13870907 0.84 NPC1 (0.53) KDM4ENPC1ALDH1A1SMN1; SMN2RAB9A
SCHEMBL14500754 0.81 NPC1 (0.53) KDM4ENPC1ALDH1A1SMN1; SMN2RAB9A
SCHEMBL13870944 0.81 KATNA1 (0.44) KDM4ENPC1ALDH1A1SMN1; SMN2RAB9A
SCHEMBL13870922 0.80 ALDH1A1 (0.50) KDM4ENPC1ALDH1A1SMN1; SMN2RAB9A
SCHEMBL31552887 0.80 KDM4E (0.63) KDM4ENPC1ALDH1A1SMN1; SMN2RAB9A
SCHEMBL13870921 0.79 SMN1; SMN2 (0.54) KDM4ENPC1ALDH1A1SMN1; SMN2RAB9A
SCHEMBL31439162 0.79 PDGFRB (0.61) KDM4ENPC1ALDH1A1SMN1; SMN2RAB9A
SCHEMBL13399627 0.79 NPC1 (0.47) KDM4ENPC1ALDH1A1SMN1; SMN2RAB9A
SCHEMBL13870938 0.79 NQO2 (0.46) KDM4ENPC1ALDH1A1SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IK, G6PD, EYA2 KDM4E 2874/4885NPC1 2112/4885ALDH1A1 111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.